BY IDA JORGENSEN
-
Abbvie drug gets European approval for new therapeutic area
Rinvoq is currently accepted for 8 various signs in the EU.
-
Stock analyst predicts exposed biotech companies to lose out in tariff war
On Monday, numerous financial experts increased the caution flag of a monetary situation, and although life scientific research supplies are currently recouping on Tuesday, biotech…
-
Life science stocks should be “safe haven”: Equity analyst points to three factors behind market dive
Pharma supplies dive Monday in spite of medication import exceptions from brand-new United States tolls. Equity expert indicate a disorderly market and 2 additional variables behin…
-
WSA hearing aid beats rival in new study
Individuals experienced more clear speech understanding with the WSA item contrasted to the completing item.
-
Novo Nordisk sighs relieved after US tariff exemption – but customs uncertainty remains high
The Danish drugmaker resources over fifty percent of its sales in the United States, while just a fifth of its manufacturing lies in the nation.
-
WSA hearing aid beats rival in new study
Participants experienced clearer speech understanding with the WSA product compared to the competing product.
-
Agency rules that Novo Nordisk is allowed to pay for employees’ medicines
According to Novo Nordisk’s human resources supervisor, the business had no actual questions concerning the end result, yet states that they “think of it when vital voi…
-
J&J changes strategy after head-to-head study with AstraZeneca drug: Targeting personalized medicine to cure lung cancer
Johnson & Johnson will certainly concentrate extra on accuracy medication in the future.
-
Ellab’s chairman explains CEO’s immediate departure: “We’re changing captain – not strategy”
Ellab has actually not accomplished its development target over the previous year, states Chairman Anders Hedegaard.
-
WSA targets global lead in hearing aid production
Jan Makela, Chief Executive Officer of WS Audiology, thinks the business is currently the biggest in its area in regards to the variety of listening devices.
